https://orcid.org/0000-0002-7141-3924
![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
"Letter to the editor: reflections on the future of medical cannabis research for depression." Expert Review of Neurotherapeutics, 23(5), pp. 481–482
Declaration of interest
S. Erridge is the Head of Research at Sapphire Medical Clinics and an honorary clinical research fellow at Imperial College London.
S. Mangoo is a medical student at Imperial College London. He has no conflicts of interest to declare.
M.H. Sodergren is Chief Medical Officer at Curaleaf International, a consultant hepatopancreatobiliary surgeon at Imperial College NHS Trust, and a senior clinical lecturer at Imperial College London.
Notes on contribution
Drafting of manuscript: S Erridge, S Mangoo, MH Sodergren. Critical revision: S Erridge, S Mangoo, MH Sodergren. All authors agree to be accountable for all aspects of the work.
Reviewer disclosures
Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.
Additional information
Funding
This paper was not funded.